C. elegans

A novel pharmacogenetic model to study Parkinson's disease

Richard Nass, D. M. Miller, R. D. Blakely

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Parkinson's disease (PD) is characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta. Although the use of vertebrate and tissue culture systems continue to provide valuable insight into the pathology of the neurodegeneration, the molecular determinants involved in the etiology of the disease remain elusive. Because of the high conservation of genes and metabolic pathways between invertebrates and humans, as well as the availability of genetic strategies to identify novel proteins, protein interactions and drug targets, genetic analysis using invertebrate model systems has enormous potential in deducing the factors involved in neuronal disease. In this article, we discuss the opportunities for the use of the nematode Caenorhabditis elegans (C. elegans) for gaining insight into the molecular mechanisms and pathways involved in PD.

Original languageEnglish (US)
Pages (from-to)185-191
Number of pages7
JournalParkinsonism and Related Disorders
Volume7
Issue number3
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Pharmacogenetics
Caenorhabditis elegans
Invertebrates
Parkinson Disease
Molecular Pathology
Dopaminergic Neurons
Metabolic Networks and Pathways
Drug Interactions
Vertebrates
Proteins
Genes
Pars Compacta

Keywords

  • 6-OHDA
  • Apoptosis
  • Dopamine
  • Genetics
  • MPP
  • Necrosis
  • Nematode
  • Neurodegeneration
  • Transporter

ASJC Scopus subject areas

  • Aging
  • Clinical Neurology
  • Neurology

Cite this

C. elegans : A novel pharmacogenetic model to study Parkinson's disease. / Nass, Richard; Miller, D. M.; Blakely, R. D.

In: Parkinsonism and Related Disorders, Vol. 7, No. 3, 2001, p. 185-191.

Research output: Contribution to journalArticle

@article{160aa2736b8e46d597220b5279a42612,
title = "C. elegans: A novel pharmacogenetic model to study Parkinson's disease",
abstract = "Parkinson's disease (PD) is characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta. Although the use of vertebrate and tissue culture systems continue to provide valuable insight into the pathology of the neurodegeneration, the molecular determinants involved in the etiology of the disease remain elusive. Because of the high conservation of genes and metabolic pathways between invertebrates and humans, as well as the availability of genetic strategies to identify novel proteins, protein interactions and drug targets, genetic analysis using invertebrate model systems has enormous potential in deducing the factors involved in neuronal disease. In this article, we discuss the opportunities for the use of the nematode Caenorhabditis elegans (C. elegans) for gaining insight into the molecular mechanisms and pathways involved in PD.",
keywords = "6-OHDA, Apoptosis, Dopamine, Genetics, MPP, Necrosis, Nematode, Neurodegeneration, Transporter",
author = "Richard Nass and Miller, {D. M.} and Blakely, {R. D.}",
year = "2001",
doi = "10.1016/S1353-8020(00)00056-0",
language = "English (US)",
volume = "7",
pages = "185--191",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - C. elegans

T2 - A novel pharmacogenetic model to study Parkinson's disease

AU - Nass, Richard

AU - Miller, D. M.

AU - Blakely, R. D.

PY - 2001

Y1 - 2001

N2 - Parkinson's disease (PD) is characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta. Although the use of vertebrate and tissue culture systems continue to provide valuable insight into the pathology of the neurodegeneration, the molecular determinants involved in the etiology of the disease remain elusive. Because of the high conservation of genes and metabolic pathways between invertebrates and humans, as well as the availability of genetic strategies to identify novel proteins, protein interactions and drug targets, genetic analysis using invertebrate model systems has enormous potential in deducing the factors involved in neuronal disease. In this article, we discuss the opportunities for the use of the nematode Caenorhabditis elegans (C. elegans) for gaining insight into the molecular mechanisms and pathways involved in PD.

AB - Parkinson's disease (PD) is characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta. Although the use of vertebrate and tissue culture systems continue to provide valuable insight into the pathology of the neurodegeneration, the molecular determinants involved in the etiology of the disease remain elusive. Because of the high conservation of genes and metabolic pathways between invertebrates and humans, as well as the availability of genetic strategies to identify novel proteins, protein interactions and drug targets, genetic analysis using invertebrate model systems has enormous potential in deducing the factors involved in neuronal disease. In this article, we discuss the opportunities for the use of the nematode Caenorhabditis elegans (C. elegans) for gaining insight into the molecular mechanisms and pathways involved in PD.

KW - 6-OHDA

KW - Apoptosis

KW - Dopamine

KW - Genetics

KW - MPP

KW - Necrosis

KW - Nematode

KW - Neurodegeneration

KW - Transporter

UR - http://www.scopus.com/inward/record.url?scp=0035028904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035028904&partnerID=8YFLogxK

U2 - 10.1016/S1353-8020(00)00056-0

DO - 10.1016/S1353-8020(00)00056-0

M3 - Article

VL - 7

SP - 185

EP - 191

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - 3

ER -